1702 related articles for article (PubMed ID: 19185021)
1. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
[TBL] [Abstract][Full Text] [Related]
2. Abnormal excitability of premotor-motor connections in de novo Parkinson's disease.
Buhmann C; Gorsler A; Bäumer T; Hidding U; Demiralay C; Hinkelmann K; Weiller C; Siebner HR; Münchau A
Brain; 2004 Dec; 127(Pt 12):2732-46. PubMed ID: 15509619
[TBL] [Abstract][Full Text] [Related]
3. MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's disease.
Hidding U; Bäumer T; Siebner HR; Demiralay C; Buhmann C; Weyh T; Moll C; Hamel W; Münchau A
Mov Disord; 2006 Sep; 21(9):1471-6. PubMed ID: 16703590
[TBL] [Abstract][Full Text] [Related]
4. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinson's disease.
Herzog J; Möller B; Witt K; Pinsker MO; Deuschl G; Volkmann J
Mov Disord; 2009 Jun; 24(8):1206-10. PubMed ID: 19412937
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
[TBL] [Abstract][Full Text] [Related]
6. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
[TBL] [Abstract][Full Text] [Related]
7. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.
Rodriguez-Oroz MC; Obeso JA; Lang AE; Houeto JL; Pollak P; Rehncrona S; Kulisevsky J; Albanese A; Volkmann J; Hariz MI; Quinn NP; Speelman JD; Guridi J; Zamarbide I; Gironell A; Molet J; Pascual-Sedano B; Pidoux B; Bonnet AM; Agid Y; Xie J; Benabid AL; Lozano AM; Saint-Cyr J; Romito L; Contarino MF; Scerrati M; Fraix V; Van Blercom N
Brain; 2005 Oct; 128(Pt 10):2240-9. PubMed ID: 15975946
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease.
Timmermann L; Braun M; Groiss S; Wojtecki L; Ostrowski S; Krause H; Pollok B; Südmeyer M; Ploner M; Gross J; Maarouf M; Voges J; Sturm V; Schnitzler A
Mov Disord; 2008 Jan; 23(2):218-27. PubMed ID: 18044706
[TBL] [Abstract][Full Text] [Related]
9. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
[TBL] [Abstract][Full Text] [Related]
10. Subthalamic nucleus stimulation modulates motor cortex oscillatory activity in Parkinson's disease.
Devos D; Labyt E; Derambure P; Bourriez JL; Cassim F; Reyns N; Blond S; Guieu JD; Destée A; Defebvre L
Brain; 2004 Feb; 127(Pt 2):408-19. PubMed ID: 14691060
[TBL] [Abstract][Full Text] [Related]
11. Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's disease.
Fraix V; Pollak P; Vercueil L; Benabid AL; Mauguière F
Clin Neurophysiol; 2008 Nov; 119(11):2513-8. PubMed ID: 18783985
[TBL] [Abstract][Full Text] [Related]
12. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
[TBL] [Abstract][Full Text] [Related]
13. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
[TBL] [Abstract][Full Text] [Related]
14. The nature and time course of cortical activation following subthalamic stimulation in Parkinson's disease.
Kuriakose R; Saha U; Castillo G; Udupa K; Ni Z; Gunraj C; Mazzella F; Hamani C; Lang AE; Moro E; Lozano AM; Hodaie M; Chen R
Cereb Cortex; 2010 Aug; 20(8):1926-36. PubMed ID: 20019146
[TBL] [Abstract][Full Text] [Related]
15. Subthalamic nucleus stimulation in Parkinson's disease patients intolerant to levodopa.
Lyons KE; Davis JT; Pahwa R
Stereotact Funct Neurosurg; 2007; 85(4):169-74. PubMed ID: 17259749
[TBL] [Abstract][Full Text] [Related]
16. Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson disease.
Mir P; Matsunaga K; Gilio F; Quinn NP; Siebner HR; Rothwell JC
Neurology; 2005 Jun; 64(11):1906-12. PubMed ID: 15955942
[TBL] [Abstract][Full Text] [Related]
17. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
18. Replacement of dopaminergic medication with subthalamic nucleus stimulation in Parkinson's disease: long-term observation.
Romito LM; Contarino MF; Vanacore N; Bentivoglio AR; Scerrati M; Albanese A
Mov Disord; 2009 Mar; 24(4):557-63. PubMed ID: 19097175
[TBL] [Abstract][Full Text] [Related]
19. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
[TBL] [Abstract][Full Text] [Related]
20. [The value of the internal capsule signs in the stimulation of the subthalamic nucleus in Parkinson's disease].
Escamilla F; Mínguez A; Jouma-Katati M; Meersmans Sánchez-Jofré M; Arnáiz-Urrutia C; Martín-Linares JM; Ortega-Moreno A; Arjona-Morón V
Rev Neurol; 2005 Aug 16-31; 41(4):193-7. PubMed ID: 16075395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]